Religious attendance: More cost-effective than lipitor?

Journal of the American Board of Family Medicine

Volumn 19, Issue 2, 2006, Pages 103-109

  Hall, Daniel E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; STATIN;

ARTICLE; COST EFFECTIVENESS ANALYSIS; EXERCISE; GROUPS BY AGE; HUMAN; LIFE EXPECTANCY; MORTALITY; RELIGION; RISK;

ACTUARIAL ANALYSIS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; EXERCISE; HEALTH CARE COSTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFANT; INFANT, NEWBORN; LIFE EXPECTANCY; MIDDLE AGED; MORTALITY; RELIGION; UNITED STATES;

EID: 33745883588     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.19.2.103     Document Type: Article

References (25)

1. Powell LH, Shahabi L, Thoresen CE, et al. Religion and spirituality: linkages to physical health spirituality, religion, and health: an emerging research field. Am Psychol 2003;58:36-52.
2. McCullough ME, Hoyt TH, Larson DB, et al. Religious involvement and mortality: a meta-analytic review. Health Psychol 2000;19:211-22.
3. Sloan RP, Bagiella E. Religion and health[comment]. Health Psychol 2001;20:228-9.
4. McCullough ME, Hoyt WT, Larson DB, et al. Small, robust, and important: reply to Sloan and Bagiella. Health Psychol 2001;20:228-9.
5. Rosenthal R. Effect sizes: Pearson's correlation, its display via the BESD, and alternative indices. Am Psychol 1991;46:1086-7.
6. Hall DE, Koenig HG, Meador KG. Conceptualizing "religion": how language shapes and constrains knowledge in the study of religion and health. Perspect Biol Med 2004;47:386-401.
7. Shuman JJ, Meador KG. Heal thyself: spirituality, medicine, and the distortion of Christianity. New York: Oxford University Press; 2003.
8. Anderson A. Method for constructing complete annual U.S. life tables. National Center for Health Statistics. Vital Health Statistics 1999;2(129).
9. Arias E, Anderson R, Hsiang-Ching K, et al. Deaths: final data for 2001. National Vital Statistics Reports 2003;52(3).
10. McNutt L, Wu C, Xue X, et al. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003;157:940-3.
11. Oguma Y, Sesso H, Paffenbarger R Jr, et al. Physical activity and all cause mortality in women: a review of the evidence. Br J Sports Med 2002;36:162-72.
12. Smith GD, Song F, Sheldon TA. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ 1993;306:1367-73.
13. Brazalo G. Managed care trends in statin usage. Managed Care 2001;2001:48-59.
14. The Nonprofit Almanac In Brief. 2003 [cited 2003 15 December, 2003 http://www.independentsector.org/PDFs/inbrief.pdf].
15. US Census, 2000. 2003 [cited 2003 Dec 15 http://factfinder.census.gov/ servlet/SAFFFacts?geo_id=&_geoContext=&_street=&_county= &_cityTown=&_state=&_zip=&_lang=en&_sse=on].
16. Olshansky S, Passaro D, Hershow R, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005;351:1138-45.
17. Troche CJ, Tacke J, Hinzpeter B, et al. Cost-effectiveness of primary and secondary prevention in cardiovascular diseases. Eur Heart J 1998;19 Suppl C:C59-65.
18. Ganz DA, Kuntz KM, Jacobson GA, et al. Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction. Ann Intern Med 2000;132:780-7.
19. Prosser LA, Stinnett AA, Goldman PA, et al. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med 2000;132:769-79.
20. Provenzale D. Cost-effectiveness of screening the average-risk population for colorectal cancer. Gastrointest Endosc Clin North Am 2002;12:93-109.
21. Hamel MB, Phillips RS, Davis RB, et al. Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med 1997;127:195-202.
22. Lee K, Angus DC, Abramson N. Cardiopulmonary resuscitation: what cost to cheat death? Crit Care Med 1996;24:2046-52.
23. Strawbridge WJ, Cohen RD, Shema SJ, et al. Frequent attendance at religious services and mortality over 28 years. Am J Public Health 1997;87:957-61.
24. Hummer R, Rogers R, Nam C et al. Religious involvement and US adult mortality. Demography 1999;36:273-85.
25. Bagiella E, Hong V, Sloan RP. Religious attendance as a predictor of survival in the EPESE cohorts. Int J Epidemiol 2005;14:443-51.